Patents Assigned to CSL Behring AG
  • Publication number: 20230083398
    Abstract: The present invention relates to an immunoglobulin preparation comprising immunoglobulin in a mass-volume percentage of at least 4%, wherein the concentration of oxygen dissolved in the preparation at room temperature is less than 40 ?mol/l.
    Type: Application
    Filed: July 14, 2022
    Publication date: March 16, 2023
    Applicant: CSL Behring AG
    Inventors: Werner Maeder, Reinhard Franz Bolli, Peter Lerch, Renzo Pedrussio, Liane Hoefferer
  • Publication number: 20230055416
    Abstract: The present invention relates to a method and a system of extracting a protein with high yield from a protein-comprising precipitate, in particular immunoglobulin, from human or non-human origins, such as blood plasma.
    Type: Application
    Filed: April 21, 2022
    Publication date: February 23, 2023
    Applicant: CSL BEHRING AG
    Inventor: Ibrahim EL MENYAWI
  • Publication number: 20230002444
    Abstract: The present invention relates to a method and system for extracting proteins from precipitates, particularly recombinant and/or plasma derived proteins including immunoglobulins (Ig) such as immunoglobulin G (IgG).
    Type: Application
    Filed: November 20, 2020
    Publication date: January 5, 2023
    Applicant: CSL BEHRING AG
    Inventors: Ibrahim EL MENYAWI, Marcus VON NORDHEIM
  • Patent number: 11471617
    Abstract: The invention relates to methods for generating an aerosol by nebulization of a composition comprising polyclonal immunoglobulin (Ig). The selection of an efficient membrane nebulizer and a composition optimized for nebulization with such membrane nebulizer results in a particularly efficient method of generating an aerosol for administration of Ig to the respiratory tract.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: October 18, 2022
    Assignees: CSL BEHRING AG, PARI PHARMA GMBH, MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Cédric Pierre Vonarburg, Karin Steinfuehrer, Ulrich Baumann
  • Patent number: 11419936
    Abstract: The present invention relates to an immunoglobulin preparation comprising immunoglobulin in a mass-volume percentage of at least 4%, wherein the concentration of oxygen dissolved in the preparation at room temperature is less than 40 ?mol/l.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: August 23, 2022
    Assignee: CSL Behring AG
    Inventors: Werner Maeder, Reinhard Franz Bolli, Peter Lerch, Renzo Pedrussio, Liane Hoefferer
  • Patent number: 11312746
    Abstract: The present invention relates to a method and a system of extracting a protein with high yield from a protein-comprising precipitate, in particular immunoglobulin, from human or non-human origins, such as blood plasma.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: April 26, 2022
    Assignee: CSL BEHRING AG
    Inventor: Ibrahim El Menyawi
  • Publication number: 20220118092
    Abstract: The present invention relates to the use of proline for reducing the viscosity of a protein preparation.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 21, 2022
    Applicant: CSL Behring AG
    Inventors: Reinhard Franz Bolli, Werner Maeder, Peter Lerch
  • Publication number: 20210246162
    Abstract: The present invention relates to a method and a system of extracting a protein with high yield from a protein-comprising precipitate, in particular immunoglobulin, from human or non-human origins, such as blood plasma.
    Type: Application
    Filed: May 17, 2019
    Publication date: August 12, 2021
    Applicant: CSL BEHRING AG
    Inventor: Ibrahim EL MENYAWI
  • Patent number: 10918696
    Abstract: The present invention relates generally to a method of purifying proteins. More specifically, the present inventions relates to a method of purifying haptoglobin and hemopexin from the same starting material, and uses thereof.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: February 16, 2021
    Assignee: CSL BEHRING AG
    Inventor: Nathan Brinkman
  • Patent number: 10829542
    Abstract: The invention relates to methods promoting the aggregation of Salmonella bacteria in the gut of subjects, thereby providing immune exclusion and limiting bacterial entry, therefore reducing mucosal and systemic infection.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: November 10, 2020
    Assignees: CSL BEHRING AG, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Blaise Corthésy, Gilles Bioley, Cédric Pierre Vonarburg
  • Publication number: 20200054748
    Abstract: The present invention relates to an immunoglobulin preparation comprising immunoglobulin in a mass-volume percentage of at least 4%, wherein the concentration of oxygen dissolved in the preparation at room temperature is less than 40 ?mol/l.
    Type: Application
    Filed: August 27, 2019
    Publication date: February 20, 2020
    Applicant: CSL Behring AG
    Inventors: Werner Maeder, Reinhard Franz Bolli, Peter Lerch, Renzo Pedrussio, Liane Hoefferer
  • Publication number: 20200055922
    Abstract: The present invention relates to immunoglobulin products for use in the treatment of chronic inflammatory demyelinating polyneuropathy using immunoglobulin products. In particular, the present invention provides efficacious dosing regimens.
    Type: Application
    Filed: April 20, 2018
    Publication date: February 20, 2020
    Applicant: CSL BEHRING AG
    Inventors: ORELL MIELKE, JOHN-PHILIP LAWO, BILLIE DURN, MICHAEL TORTORICI, OTHMAR ZENKER, IVO VAN SCHAIK
  • Publication number: 20190345229
    Abstract: The invention relates to methods promoting the aggregation of Salmonella bacteria in the gut of subjects, thereby providing immune exclusion and limiting bacterial entry, therefore reducing mucosal and systemic infection.
    Type: Application
    Filed: December 20, 2017
    Publication date: November 14, 2019
    Applicants: CSL BEHRING AG, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: Blaise CORTHÉSY, Gilles BIOLEY, Cédric Pierre VONARBURG
  • Patent number: 10434176
    Abstract: The present invention relates to an immunoglobulin preparation comprising immunoglobulin in a mass-volume percentage of at least 4%, wherein the concentration of oxygen dissolved in the preparation at room temperature is less than 40 ?mol/l.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: October 8, 2019
    Assignee: CSL Behring AG
    Inventors: Werner Maeder, Reinhard Franz Bolli, Peter Lerch, Renzo Pedrussio, Liane Hoefferer
  • Patent number: 10221233
    Abstract: The invention relates to methods for preparing compositions comprising secretory-like immunoglobulin, in particular secretory-like IgA and/or secretory-like IgM, and compositions obtainable by the methods.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: March 5, 2019
    Assignee: CSL BEHRING AG
    Inventors: Blaise Corthésy, Stéphanie Longet, Marius Loetscher, Sylvia Miescher, Adrian Zuercher
  • Publication number: 20180360969
    Abstract: The present invention relates to the use of proline for reducing the viscosity of a protein preparation.
    Type: Application
    Filed: June 15, 2018
    Publication date: December 20, 2018
    Applicant: CSL Behring AG
    Inventors: Reinhard Franz Bolli, Werner Maeder, Peter Lerch
  • Patent number: 10144774
    Abstract: The invention relates to a modified process for the purification of IgG, improving the yield of IgG per liter of starting material without compromising the quality of the product.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: December 4, 2018
    Assignee: CSL BEHRING AG
    Inventors: Ibrahim El Menyawi, Doreen Siegemund
  • Patent number: 10137197
    Abstract: The present invention relates to the use of proline for reducing the viscosity of a protein preparation.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: November 27, 2018
    Assignee: CSL Behring AG
    Inventors: Reinhard Franz Bolli, Werner Maeder, Peter Lerch
  • Patent number: 9937229
    Abstract: The present invention relates generally to a method of purifying proteins. More specifically, the present inventions relates to a method of purifying haptoglobin and hemopexin from the same starting material, and uses thereof.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: April 10, 2018
    Assignee: CSL Behring AG
    Inventor: Nathan Brinkman
  • Patent number: 9932392
    Abstract: The invention relates to compositions and methods to prevent enteric infection in a subject at risk of such infection. In particular, the invention relates to the prevention of recurrence of infection by Clostridium difficile.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: April 3, 2018
    Assignees: CSL BEHRING AG, BETH ISRAEL DEACONESS MEDICAL CENTER INC
    Inventors: Ciaran Kelly, Xinhua Chen, Sylvia Miescher, Martin Spycher, Sandra Wymann, Adrian Zuercher